Overview: Chlamydia Trachomatis IgM TestIntroduction: The Chlamydia Trachomatis IgM Test detects IgM antibodies to Chlamydia trachomatis, indicating recent infection causing pelvic pain or infertility. Following 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in immunology for patients with suspected Chlamydia infection.
Other Names: Chlamydia IgM Assay, Chlamydia Infection Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Chlamydia antibody testing began in the 1980s with infection research. IgM-specific assays emerged in the 1990s, and by the 2000s, immunoassays improved detection accuracy.
Purpose: Diagnoses recent Chlamydia trachomatis infection, guides treatment, and monitors antibody levels in patients with pelvic pain or infertility.
Test Parameters: 1. Chlamydia Trachomatis IgM
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like pelvic pain or infertility, and list recent antibiotic use.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document pelvic pain, infertility, or sexual history. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antibiotic therapy.
Procedural Considerations: Uses an immunoassay to measure Chlamydia trachomatis IgM antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Recent antibiotics may suppress antibody levels. Hemolysis or improper storage can degrade samples.
Clinical Significance: Positive results confirm recent Chlamydia infection, prompting antibiotic therapy. Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A gynecologist referral is advised for infertility cases.
Additional Supporting Tests: Chlamydia PCR, IgG test, or pelvic ultrasound to confirm infection or assess complications.
Test Limitations: False negatives may occur with early infection. Results require clinical correlation with history.
References: IDSA Chlamydia Guidelines, 2023; Clinical Infectious Diseases, Workowski KA, 2022.
